{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-244185","form_type":"8-K","ticker":"OACC","cik":"0002029769","company_name":"Oaktree Acquisition Corp. III Life Sciences","filed_at":"2024-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.600632+00:00","generated_at":"2026-05-30T10:11:14.382565+00:00","sec_items":["1.01","3.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oaktree Acquisition Corp. III Life Sciences prices $175M IPO at $10/unit","bullets":["Gross proceeds of $175M from 17.5M units at $10.00 each; units trade on Nasdaq as OACCU.","Each unit comprises one Class A share and 1/5 redeemable warrant exercisable at $11.50.","Underwriters have 45-day over-allotment option for up to 2.625M additional units.","Sponsor purchased 550,000 private placement units at $10 each, generating $5.5M.","Net proceeds held in trust for initial business combination; 24-month deadline to complete."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-244185","json":"https://secwatch.observer/filing/0001193125-24-244185.json","markdown":"https://secwatch.observer/filing/0001193125-24-244185.md","text":"https://secwatch.observer/filing/0001193125-24-244185.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2029769/000119312524244185/0001193125-24-244185-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2029769/000119312524244185/d847969d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:11:14.382565+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7659a49463b17df2aabf9afb33c1b2ee96a3752a","claim":"Oaktree Acquisition Corp. III Life Sciences: Adopted Amended and Restated Memorandum and Articles of Association in connection with IPO (effective 2024-10-23).","evidence_excerpt":"On October 23, 2024 and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2029769/000119312524244185/0001193125-24-244185-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-10-23"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}